Zhang et al. demonstrated that Shexiang Tongxin Dropping Pill (STDP) inhibits the ERK/MAPK signaling cascade, thereby mitigating myocardial fibrosis and cardiomyocyte hypertrophy and subsequently preventing the progression of chronic HF in mice [36]. This evidence concerns the gene MAPK1 and Myocardial fibrosis.